News
For leaders in business, failing to learn the lessons of a crisis can be disastrous. For leaders in government, when millions ...
4h
The Dispatch on MSNThe Risks of Trump’s Turn Against mRNA Vaccines
The mRNA platform enabled scientists to begin work on a vaccine within days of the publication of COVID-19’s genetic sequence. Clinical trials for an mRNA vaccine began weeks la ...
In June, the monoclonal antibody garadacimab (Andembry) was approved for prevention of HAE attacks at a dose of once monthly ...
Single-cell proteomics with RNA sequencing uncover hidden gene expression dynamics in stem cell differentiation.
Sarepta is facing a number of issues currently, including platform-level safety concerns, management credibility issues, etc.
Studying the process of brain formation illuminates just how much of development is a series of tiny miracles. Only a few ...
In the past decade there has been significant interest in studying the expression of our genetic code down to the level of ...
16h
TipRanks on MSNIonis Pharmaceuticals Gains FDA Approval for DAWNZERA
An announcement from Ionis Pharmaceuticals ( (IONS) ) is now available. On August 21, 2025, Ionis Pharmaceuticals announced that the FDA approved DAWNZERA™ (donidalorsen) for preventing hereditary ...
The approval makes donidalorsen the only treatment in the US for hereditary angioedema that is an RNA-targeted prophylactic.
The ability to correct disease-causing genetic mistakes using genome editors holds great promise in medicine, but it is not ...
Senior author Elias Sayour, M.D., Ph.D., a UF Health pediatric oncologist, said the results reveal a potential new treatment path — an alternative to surgery, radiation, and chemotherapy — with broad ...
A previously unknown virus in farmed Pacific oysters may hold the key to mass die-offs in the multimillion-dollar industry, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results